The state of disparities in opportunistic infection prophylaxis for blacks with HIV/AIDS
- PMID: 23047780
- PMCID: PMC3470654
- DOI: 10.1097/MLR.0b013e31826c85d1
The state of disparities in opportunistic infection prophylaxis for blacks with HIV/AIDS
Abstract
Objectives: The purpose of this review is to identify and analyze published studies that have evaluated disparities for opportunistic infection (OI) prophylaxis between blacks and whites with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) in the United States.
Methods: The authors conducted a web-based search of MEDLINE (1950-2009) to identify original research articles evaluating the use of OI prophylaxis between blacks and whites with HIV/AIDS. The search was conducted utilizing the following MeSH headings and search terms alone and in combination: HIV, AIDS, Black, race, ethnicity, disparities, differences, access, opportunistic infection, and prophylaxis. The search was then expanded to include any relevant articles from the referenced citations of the articles that were retrieved from the initial search strategy. Of the 29 articles retrieved from the literature search, 19 articles were excluded.
Results: Ten publications met inclusion criteria, collectively published between 1991 and 2005. The collective time periods of these studies spanned from 1987 to 2001. Four studies identified a race-based disparity in that blacks were less likely than whites to use OI prophylaxis, whereas 5 studies failed to identify such a relationship between race and OI prophylaxis. One study identified disparities for Mycobacterium avium complex prophylaxis, but not for Pneumocystis jiroveci pneumonia prophylaxis.
Conclusions: The evidence regarding race-based disparities in OI prophylaxis is inconclusive. Additional research is warranted to explore potential race-based disparities in OI prophylaxis.
Figures
Similar articles
-
Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature.Public Health Rep. 2002 May-Jun;117(3):233-51; discussion 231-2. doi: 10.1093/phr/117.3.233. Public Health Rep. 2002. PMID: 12432135 Free PMC article. Review.
-
Evaluating HIV/AIDS disparities for blacks in the United States: a review of antiretroviral and mortality studies.J Natl Med Assoc. 2009 Dec;101(12):1221-9. doi: 10.1016/s0027-9684(15)31133-0. J Natl Med Assoc. 2009. PMID: 20070010 Review.
-
Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.MMWR CDC Surveill Summ. 1999 Apr 16;48(2):1-22. MMWR CDC Surveill Summ. 1999. PMID: 12412613
-
High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States.Med Care. 2005 Sep;43(9 Suppl):III23-30. doi: 10.1097/01.mlr.0000175631.34438.1e. Med Care. 2005. PMID: 16116306
-
Racial differences in the use of drug therapy for HIV disease in an urban community.N Engl J Med. 1994 Mar 17;330(11):763-8. doi: 10.1056/NEJM199403173301107. N Engl J Med. 1994. PMID: 8107743
Cited by
-
Utilization of immunological ratios in HIV: Implications for monitoring and therapeutic strategies.Medicine (Baltimore). 2024 Mar 1;103(9):e37354. doi: 10.1097/MD.0000000000037354. Medicine (Baltimore). 2024. PMID: 38428854 Free PMC article.
-
Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells.Vaccine. 2020 Feb 18;38(8):1998-2004. doi: 10.1016/j.vaccine.2020.01.002. Epub 2020 Jan 14. Vaccine. 2020. PMID: 31948820 Free PMC article.
References
-
- Brooks JT, Kaplan JE, Holmes KK, et al. HIV-associated opportunistic infections--going, going, but not gone: the continued need for prevention and treatment guidelines. Clin Infect Dis. 2009;48:609–611. - PubMed
-
- Keruly JC, Moore RD. Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006. Clin Infect Dis. 2007;45:1369–1374. - PubMed
-
- Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1989;38(Suppl 5):1–9. - PubMed
-
- Kaplan JE, Benson C, Holmes KH, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58:1–207. - PubMed
-
- Palella FJ, Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
